Common TitleTURQUOISE-III
Official Title Sustained Virologic Response of 100% in HCV Genotype 1b Patients with Cirrhosis Receiving Ombitasvir/Paritaprevir/r and Dasabuvir for 12 Weeks
Phase Phase III
ClinicalTrials.gov NCT02219503
Treatments
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir
Tradename:Viekira PakOther Names:3DClass:DiscontinuedFunding
IndustryAbbVie